Ai Feedback
Exact(14)
In this trial, grade 3 or 4 thrombocytopenia occurred in 33% of the chemotherapy-naïve patients.
The administration of tranexamic acid is supported by a large, multicentre, randomised clinical trial (grade 1A).
In the ASPECCT trial, Grade 3-4 skin AEs occurred in 62 patients (13%) given panitumumab and 48 patients (10%) given cetuximab [ 19].
There were no grade ≥3 bleeding events in the current trial; grade 1 epistaxis was observed, occurring in 22 % of patients overall.
In the pivotal Intergroup 0099 trial, grade 3 and 4 adverse effects in patients treated with concurrent chemoradiation therapy nearly doubled those received irradiation only.
In the CALGB 9221 trial, grade 3 4 leukocytopenia occurred in 59%, granulocytopenia in 81% and thrombocytopenia in 70% of patients receiving azacitidine.
Similar(46)
Specifically eyes from the MIVI-TRUST programme with concurrent SD-OCT and TD-OCT at baseline and day 28 were included, and the study concluded that SD-OCT may be superior for formal clinical trial grading due to greater inter-reader reproducibility.
The highest level of evidence was provided by three randomised controlled trials (grade IC).
In phase II trials, grade 3 or 4 neutropenia was observed in 98% of patients.
The system assigns a level of evidence to each study with methodological designs such as high quality randomized controlled trials graded as a level I, whereas case series' and reports are assigned a level IV.
Reasons for this unpopularity include (1) the heavy adverse effects reported in both trials (grades 3 4 pain, fatigue, and hematologic toxicities were significantly more common in the IP cohort), (2) the insertion and management of the IP catheter, and (3) the associated complications and worse quality-of-life scores observed in the experimental arms [23], [24].
Write better and faster with AI suggestions while staying true to your unique style.
Since I tried Ludwig back in 2017, I have been constantly using it in both editing and translation. Ever since, I suggest it to my translators at ProSciEditing.

Justyna Jupowicz-Kozak
CEO of Professional Science Editing for Scientists @ prosciediting.com